Literature DB >> 7040367

Purification and further characterization of the Ca2+-activated proteinase specific for the intermediate filament proteins vimentin and desmin.

W J Nelson, P Traub.   

Abstract

A calcium (Ca2+)-activated, neutral proteinase has been purified from Ehrlich ascites tumor cells. The protocol used has resulted in a 3,600-fold purification of the enzyme in a yield of 21% from the Ehrlich ascites tumor cell postnuclear supernatant. The purified proteinase has a high substrate specificity for the intermediate filament subunit proteins, vimentin and desmin, and showed no activity towards other intermediate filament proteins except a 60,000-dalton protein of the cytokeratins. Also, there was no degradation of actin, tubulin, the major constituent proteins of myofibrils and several standard proteins. Characterization of the purified proteinase has shown that it is activated by Ca2+ (10 to 100 microM), is probably calmodulin-independent and irreversibly loses activity when incubated in the presence of Ca2+ without substrate. The enzyme has a Km of 1.7 x 10(-8) M for vimentin and 5.2 x 10(-7) M for desmin. The proteinase has a major subunit of 72,000 daltons which has the catalytic center and a minor component of 29,000 daltons; by gel permeation chromatography it has an apparent molecular weight of 100,000. It requires a reduced sulfhydryl group for activity and can be inhibited by sulfhydryl-blocking reagents. The high substrate specificity of the proteinase indicates that it is involved in the regulation of the distribution and turnover of vimentin- and desmin-containing intermediate filaments.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040367

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Muscle fibre breakdown in venom-induced muscle degeneration.

Authors:  J B Harris; R Vater; M Wilson; M J Cullen
Journal:  J Anat       Date:  2003-04       Impact factor: 2.610

2.  Fish muscle cytoskeleton integrity is not dependent on intact thin filaments.

Authors:  R G Taylor; I Papa; C Astier; F Ventre; Y Benyamin; A Ouali
Journal:  J Muscle Res Cell Motil       Date:  1997-06       Impact factor: 2.698

3.  The effects of a calcium dependent protease on the ultrastructure and contractile mechanics of skinned uterine smooth muscle.

Authors:  J R Haeberle; S A Coolican; A Evan; D R Hathaway
Journal:  J Muscle Res Cell Motil       Date:  1985-06       Impact factor: 2.698

4.  Inhibitory effects of spermine and spermidine on muscle calpain II.

Authors:  P Johnson; J L Hammer
Journal:  Experientia       Date:  1990-03-15

5.  A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain.

Authors:  D C Shields; K E Schaecher; T C Saido; N L Banik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

6.  The breakdown of the individual neurofilament proteins by cathepsin D.

Authors:  M Banay-Schwartz; D Dahl; K S Hui; A Lajtha
Journal:  Neurochem Res       Date:  1987-04       Impact factor: 3.996

7.  Purification and partial characterization of two forms of Ca2+-activated neutral protease from calf brain synaptosomes and spinal cord.

Authors:  M N Malik; M D Fenko; H M Wisniewski
Journal:  Neurochem Res       Date:  1984-02       Impact factor: 3.996

8.  Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins.

Authors:  W J Nelson; P Traub
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

9.  Interaction of the intermediate filament protein vimentin with ribosomal subunits and ribosomal RNA in vitro.

Authors:  P Traub; W J Nelson
Journal:  Mol Biol Rep       Date:  1982-11-30       Impact factor: 2.316

10.  Endogenous, Ca(2+)-dependent cysteine-protease cleaves specifically the ryanodine receptor/Ca2+ release channel in skeletal muscle.

Authors:  V Shoshan-Barmatz; S Weil; H Meyer; M Varsanyi; L M Heilmeyer
Journal:  J Membr Biol       Date:  1994-12       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.